Literature DB >> 19144952

An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria.

Juergen Harms, Stephan Lautenschlager, Christoph E Minder, Elisabeth I Minder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19144952     DOI： 10.1056/NEJMc0805682

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  [Hereditary metabolic diseases with cutaneous manifestations : An update].

Authors:  J Frank; P Poblete-Gutiérrez
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

3.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

4.  An α-MSH analog in erythropoietic protoporphyria.

Authors:  Thomas A Luger; Markus Böhm
Journal:  J Invest Dermatol       Date:  2015-04       Impact factor: 8.551

5.  [Erythropoietic protoporphyria. A rare differential diagnosis among photosensitive diseases].

Authors:  C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

Review 6.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 7.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

8.  [Dermoscopic changes in melanocytic nevi during use of melanotan II].

Authors:  R Mang; D Krahl; T Assmann
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

9.  Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal.

Authors:  Elisabeth I Minder; Xiaoye Schneider-Yin; Christoph E Minder
Journal:  Health Qual Life Outcomes       Date:  2010-06-21       Impact factor: 3.186

Review 10.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.